XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2023
Cash Flows from Operating Activities      
Net loss $ (67,534) $ (38,698)  
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation 65,698 64,669  
Amortization 72,661 82,617  
Share-based compensation expense 45,957 54,185  
Amortization of discount on convertible debt and debt issuance costs 3,567 4,466  
Non-cash restructuring charges 319 0  
Gains on disposal of property, plant and equipment (101) 0  
Unrealized gains on foreign currency remeasurements and transactions (14,462) (22,273)  
Loss (earnings) from equity investments 243 (613)  
Deferred income taxes (39,627) (14,479)  
Loss on debt extinguishment 0 6,835  
Increase (decrease) in cash from changes in (net of effect of acquisitions):      
Accounts receivable 116,295 (1,326)  
Inventories (16,709) 7,514  
Accounts payable 41,985 (42,865)  
Contract liabilities (9,769) 44,419  
Income taxes (2,806) (8,633)  
Accrued compensation and benefits 7,482 (44,910)  
Other operating net liabilities (4,396) (11,330)  
Net cash provided by operating activities 198,803 79,577  
Cash Flows from Investing Activities      
Additions to property, plant & equipment (62,197) (138,990)  
Purchases of businesses, net of cash acquired 0 (5,488,556)  
Other investing activities (1,978) (711)  
Net cash used in investing activities (64,175) (5,628,257)  
Cash Flows from Financing Activities      
Proceeds from borrowings of Revolving Credit Facility 0 65,000  
Payments on existing debt (18,683) (996,429)  
Payments on convertible notes 0 (3,561)  
Debt issuance costs 0 (126,516)  
Equity issuance costs 0 (42,000)  
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan 14,947 7,425  
Payments in satisfaction of employees' minimum tax obligations (13,876) (40,885)  
Other financing activities (268) (292)  
Net cash provided by (used in) financing activities (17,880) 3,912,742  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (9,458) (42,273)  
Net increase (decrease) in cash, cash equivalents, and restricted cash 107,290 (1,678,211)  
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 837,566 2,582,371 $ 2,582,371
Cash, Cash Equivalents, and Restricted Cash at End of Period 944,856 904,160 837,566
Supplemental Information      
Cash paid for interest 67,320 45,963  
Cash paid for income taxes 14,810 14,920  
Additions to property, plant & equipment included in accounts payable 39,264 71,035  
Non-Cash Investing and Financing Activities      
Conversion of Series A preferred stock to common stock 445,319 0  
Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents      
Restricted cash 10,000    
Cash, cash equivalents, and restricted cash 941,081 898,501 833,333
Restricted cash, non-current 3,775 5,659  
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows 944,856 904,160 $ 837,566
Series B Preferred Shares      
Cash Flows from Financing Activities      
Proceeds from issuance of Series B Preferred Shares 0 1,400,000  
Term A Loan      
Cash Flows from Financing Activities      
Proceeds from borrowing of Term Facility 0 850,000  
Term B Loan      
Cash Flows from Financing Activities      
Proceeds from borrowing of Term Facility $ 0 $ 2,800,000